community-acquired pneumonia
Conditions
Interventions
Children hospitalized for pneumonia were divided into 2 groups
Group I: experimental, received zinc sulfate orally 0.5% zinc syrup dose was 10 mg / day which corresponded to 2cc for children under 1
Zinc Sulfate
Placebo
Administration, Oral
Sponsors
Autonomous Service Antonio Patricio de Alcalá University Hospital (SAHUAPA)
Eligibility
Sex/Gender
All
Age
No minimum to 5 Years
Inclusion criteria
Inclusion criteria: 1.The diagnosis of pneumonia was considered in that child with fever (T ° = 38.5 ° C) in the presence of signs and symptoms such as respiratory distress, retractions or draws and cough accompanied by radiological changes.
Exclusion criteria
Exclusion criteria: The following were excluded from the study: 1. Patients with congenital malformations 2. Patients immunosuppressed by drugs or primary diseases of the immune system 3. Patients with suspected foreign body aspiration 4. Previous hospitalizations in the last 4 weeks 5. Presence of wheezing as dominant findings.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Resolution of pneumonia (Time measured in hours required to normalize the clinical elements that defined the pneumonia). Measurement time: from the moment of admission until normal | — |
Secondary
| Measure | Time frame |
|---|---|
| Remission rate of clinical indicators of pneumonia in percentage. Measurement time: at 72 hours’ intervention started 2. Therapeutic failure (Need to change the initial antibiotic, the appearance of complications or the persistence of hypoxemia). Measurement time: at 72 hours’ intervention started 3. Adverse effects (Any reaction related to the intervention). Measurement time: up to 14 days. | — |
Countries
venezuela
Contacts
Public ContactElias Kassisse El Hage
Herminda Martin Clinical Hospital
Outcome results
None listed